Please assess the completion status of the following clinical trial:

Trial Title: ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Male and female ambulatory outpatients being seen in a participating physicians office for routine care,~* Patients with a clinical diagnosis of COPD and already being treated with the maintenance therapy with long-acting anticholinergic (Tiotropium (Spiriva® HandiHaler® or Respimat®) at least 1 month and within product label~* Patient fluent in language of questionnaire and having the cognitive and functional abilities required to fill in the questionnaire alone~Exclusion criteria:~* Uncooperative patients as judged by the physician~* Patients with any conditions excluded as per Country specific package insert~* Patients currently enrolled in any clinical trial which requires a change in medication for their respiratory problems.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with COPD (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).